本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

和黄医药

15.59
+1.7012.24%
成交量:11.15万
成交额:172.38万
市值:26.66亿
市盈率:77.95
高:15.85
开:15.12
低:15.08
收:13.89
数据加载中...
2020/01/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/20

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/29

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/25

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/17

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/30

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/09/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/30

[补充]招股说明书

Filing under Securities Act Rules 163/433 of free writing prospectuses
2019/09/25

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]